Ascend Gene & Cell Therapies
Huda Naas currently serves as a Bio-Assay Associate III at Ascend Advanced Therapies, a role assumed in April 2024. Prior experience includes positions at Beacon Therapeutics as a Bio-Assay Associate III and II from June 2023 to March 2024, and at AGTC as a Research Associate II from August 2021 to June 2023. Huda also held the title of Scientist I at Thermo Fisher Scientific between November 2020 and July 2021, and worked as a Laboratory Assistant at BioReference Laboratories in mid-2020. Huda's academic qualifications include a Master's degree in Biotechnology from Florida Institute of Technology and a Bachelor's degree in Biomedical Sciences from the same institution. Huda is currently pursuing an MBA at the University of South Florida Muma College of Business, with an expected completion in May 2026.
This person is not in any offices
Ascend Gene & Cell Therapies
Ascend Gene & Cell Therapies supports manufacturing and process development projects from design through to clinical and commercial scales. They partner with biotechnology teams to embed scalable manufacturing in their operations from the beginning. They respond to customer inquiries by phone and contact form.